Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study
- 1 September 1993
- Vol. 72 (5) , 1679-1684
- https://doi.org/10.1002/1097-0142(19930901)72:5<1679::aid-cncr2820720531>3.0.co;2-w
Abstract
Background. Abnormal interaction with the extracellular matrix is a basic property of malignant cells. Type III collagen is a major constituent of the extracellular matrix of soft tissues. Methods. Deposition of the aminoterminal propeptide of type III procollagen (PIIINP) was studied in benign (n = 41), borderline (n = 4), and malignant (n = 32) human ovarian tumors using the avidin-biotin-immunoperoxidase technique and affinity-purified antibodies to human PIIINP. It was then compared with the serum PIIINP concentrations of the patients at the time of operation. Results. In malignant tumors, the distribution of PIIINP was irregular both close to the epithelial cancer cells and further away, in the stroma. Another feature typical of malignant tumors was the varying staining intensity of the PIIINP-positive fibers. The benign tumors were characterized by a regular organization and an intensive staining of PIIINP. Borderline tumors showed a slightly decreased staining intensity and altered PIIINP distribution. A significant positive correlation was found between the PIIINP concentration in serum and the degree of irregularity in the distribution of PIIINP. Conclusions. These preliminary results indicate that malignant transformation in ovarian tumors is associated with disintegration of adjacent collagenous structures and with alterations in type III procollagen metabolism, which also leads to increased serum PIIINP levels. They suggest that biochemical or immunohistochemical detection of the PIIINP antigen could be clinically useful in ovarian tumors.Keywords
This publication has 10 references indexed in Scilit:
- Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumorsInternational Journal of Cancer, 1990
- Simultaneous Evaluation of Epithelial Cell Function by CA 125 and Stromal Cell Activity by Aminoterminal Propeptide of Type III Procollagen (PIIINP) in Ovarian CarcinomaAnnals of Medicine, 1990
- Tenascin: An Extracellular Matrix Protein Prominent in Specialized Embryonic Tissues and TumorsAnnual Review of Cell Biology, 1989
- Collagen type III in ovarian tumors. Histological, immunohistochemical and ultrastructural findingsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1989
- Aminoterminal propeptide of type III procollagen in serum—an indicator of clinical behavior of advanced ovarian carcinoma?International Journal of Cancer, 1988
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Collagen Fibrillogenesis in Human SkinaAnnals of the New York Academy of Sciences, 1985
- Purification and characterization of the N-terminal propeptide of human type III procollagenBiochemical Journal, 1985
- Enzymes of collagen synthesis and type iii procollagen amino‐propeptide in serum from nigerians with hepatocellular carcinoma and other malignant diseasesInternational Journal of Cancer, 1982
- The Biosynthesis of Collagen and Its DisordersNew England Journal of Medicine, 1979